Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

Research

High tidal volume ventilation does not exacerbate acid-induced lung injury in infant rats

The impact of mechanical ventilation with high VT-low PEEP in infant rats with preinjured lungs is unknown.

Research

Yarning about yarning as a legitimate method in Indigenous Research

This article demonstrates the credibility and rigor of yarning, an Indigenous cultural form of conversation, through its use as a data gathering tool

People

Amelia Freeman

Amelia Freeman's staff profile at The Kids Research Institute Australia

News & Events

Child Health Research Seminars March 2013

The Kids for Child Health Research presents seminars from our leading researchers every Friday. They are designed to inform both the scientific co

embrace exclusive

Read the latest edition of our magazine, embrace exclusive, right here.

Scientific Launch Speakers

Scientific Launch Speakers Professor Liz Davis @ProfLizDavis  @CDCTelethonKids Professor Davis is the Co-Director of the JDRF Global Centre of

All through the night

For the parent of a child living with diabetes, sleep no longer represents the relaxing slumber that it used to.

Research

Start Stronger, Live Longer Resource Manual for Aboriginal Health Workers

This resource kit for Aboriginal health workers is an exciting milestone in the Rio Tinto Aboriginal Health partnership with The Kids Research Institute Australia

Research

A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC

Esophageal squamous cell carcinoma (ESCC) is a prevalent malignant tumor of the digestive tract with a low 5-year survival rate due to the lack of effective treatment methods. Although therapeutic monoclonal antibodies (mAbs) now play an important role in cancer therapy, effective targeted mAbs are still lacking for ESCC. 

Research

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

Respiratory syncytial virus is the second most common cause of infant mortality and a major cause of morbidity and mortality in older adults (aged >60 years). Efforts to develop a respiratory syncytial virus vaccine or immunoprophylaxis remain highly active.